Myriad Interactive Media Inc. Signs Licensing Agreement with Artificial Life on its Medical Application Development Source Code to Be Used in Medical Marijuana Industry
July 01, 2014 at 07:17 am EDT
Share
Myriad Interactive Media Inc. have closed technology licensing agreement for mobile medical application to be used in the Medical Marijuana industry. The company has signed source code licensing agreement with Artificial Life, Inc. for its software code repository related to its medical applications which have seen a tremendous success in the diabetes markets.
Artificial Life, Inc. is an incubator and investor, investment scout and business advisor. The Company focuses on technology areas, including mobile and wireless technology and content, Internet technology and content, Internet of Things, Augmented Reality, Virtual Reality, games, social networks, new media, interactive television, banking and finance software, artificial intelligence applications, genetic algorithms, neural networks, production optimization and logistics. It enables companies to find investment targets with a focus on Asia and Greater China, and Central Europe. It enables companies to enter new markets and enables them to raise funds for their expansion. The Company offers products, including Opus-M Version 2.0, MobileBooster, Opus-M Health, GluCoMo, Opus-M Health: Neurodermatitis, MoPA-TV, Opus-M Social, EcoChamp, ALife-PortfolioManager, SmartEngine and 3D Game Engine. It also enables due diligence and valuations of targets, as well as the analysis of businesses.
Myriad Interactive Media Inc. Signs Licensing Agreement with Artificial Life on its Medical Application Development Source Code to Be Used in Medical Marijuana Industry
ARTIFICIAL LIFE, INC. 
